Why the Smallest Labels Are Having the Biggest Year

For years the assumption in dance music was simple: if you wanted to matter, you needed to be based in Berlin, London, or LA. I've watched that assumption crack from a strange vantage point - running a label out of Bali, built by two people who started in Kyiv.

Recent industry reporting on where dance music actually grows now points to something outside the traditional centers. Regional scenes are reaching real, global audiences through platforms that don't care where you're from, only whether the track is good. That's not a marketing story. It's a distribution story, and it changes who gets to build something that lasts.

That matches exactly what happened with MANTRAPEOPLE. We didn't launch the label in a music capital. We launched it from a residency in Bali, with a roster we built ourselves - Zenøn, Anton Bodnar, Mantramn, Minörs - artists we knew personally, not names an agency pitched us. Every one of them was chosen because the sound fit, not because a spreadsheet said they'd perform well.

I think the reason small, founder-led labels are working right now is that they're solving a problem the big machine can't. A major label is built to promote a catalog. A small label, run by someone who's actually stood behind the decks, is built to protect a sound. Those are different jobs, and right now, listeners can tell the difference.

If you're an artist deciding who to work with, this is worth sitting with. The size of a label's following says less than it used to. What matters more is whether the person running it has actually built something themselves - a residency, a room, a reputation - rather than just a contact list.

This is the same instinct I bring into consulting conversations. When someone asks me whether to sign with a bigger name or stay independent longer, I'm not looking at follower counts. I'm asking who's actually going to pick up the phone when a release doesn't perform the way it should.

The scene rewards specificity now, not size. That's good news if you're small and serious. It's a harder pill if you're big and generic.